Project Grant R35GM154993

Award Date 7/15/24
Completion Date 5/31/29
Dollars Obligated $1.1M
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Santa Barbara, CA 93106, USA
Similar Awards
This Project Grant award from the National Science Foundation (NSF) under the Biological Sciences program (CFDA 47.074) provides $369,297 to San Francisco State University (SFSU) to develop a synthetic transhydrogenation module to enhance the production of valuable chemicals using engineered organisms. The key objectives are to: Elucidate the structural mechanisms underlying the autoregulation of the GltAB-GudB enzyme complex in Bacillus subtilis, which regulates glutamate metabolism and impacts...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training (CFDA 93.859) program, is focused on advancing the understanding of the mechanisms of iron-sulfur enzymes. The $647,301 award, effective February 1, 2025 through January 31, 2030, will fund research at the Massachusetts Institute of Technology (MIT) to: Develop synthetic models of iron-sulfur enzyme intermediates to elucidate their reaction...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) provides $761,271 to the University of Illinois to conduct research on the physiology of oxidative stress in bacteria. The goal is to detail the threats that oxygen poses, the defenses that organisms have evolved, and the situations in which oxidative stress impacts microbial fate. Key focus areas include: 1) identifying the enzymes...
This Project Grant award of $1,092,018 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) will fund research into two enabling approaches for chemical synthesis: nucleophilic cobalt photocatalysis and organic single-electron photoreductants. The primary objectives are to expand the breadth of carbon radical precursors available to synthetic organic chemists, which will benefit medicinal chemistry and human...
The National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training federal grant program (CFDA 93.859), awarded a $385,298 Project Grant to the Research Foundation for the State University of New York (Stony Brook University) with a project period from Feb 1, 2025 to Dec 31, 2029. The goal of this research project is to develop a new approach in biomimetic organic synthesis, utilizing visible light-driven radical pathways based on...
Under this $566,966 Project Grant from the National Science Foundation's Mathematical and Physical Sciences program (CFDA 47.049), Professor Tadhg Begley of Texas A&M University will study the enzymes involved in menaquinone biosynthesis via the futalosine pathway. The research aims to complete mechanistic characterization of the remaining four enzymes in the futalosine-dependent menaquinone pathway, which converts chorismate to 1,4-dihydroxy-6-naphthoic acid. Studies will reconstitute the...
This federal Project Grant award of $364,324 from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), supports research on the regulation of copper metabolism by hydrogen sulfide (H2S) signaling. The key objectives are to: Characterize how sulfide exposure impacts copper levels, distribution, and the expression of copper-binding proteins across various cell lines and in intestinal tissue from mice. This includes...
This $400,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) will fund research to develop an integrated computational framework for predicting and designing "photoenzymes" - enzymes that can utilize light to catalyze non-natural chemical reactions important for pharmaceutical synthesis. The key products or services to be delivered include: 1) Machine learning-enhanced...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under CFDA program 93.286 "Discovery and Applied Research for Technological Innovations to Improve Human Health", aims to develop a novel photobiocatalysis strategy to reprogram pyridoxal phosphate (PLP)-dependent enzymes as radical enzymes. The $553,775 award will support research to catalyze stereoselective intermolecular radical reactions and produce a range of non-canonical...
The National Institute of General Medical Sciences (NIGMS) awarded a $350,487 Project Grant under the Biomedical Research and Research Training Program (CFDA 93.859) to the University of Illinois to support research on "Uncovering Novel Heme Chemistry in Microbial Systems." The project aims to expand understanding of how diverse bacterial diheme proteins stabilize high-valent bis-FeIV states and leverage these intermediates for site-specific substrate oxidation. Key focus areas include...

REGULATION AND MAINTENANCE OF THIYL RADICALS IN ENZYME CATALYSIS AND PROTEIN DEGRADATION - PROJECT SUMMARY THIYL RADICALS LIE AT A PERILOUS NEXUS BETWEEN ESSENTIAL BIOLOGICAL FUNCTION AS COFACTORS IN ENZYME CATALYSIS AND TOXIC PRODUCTS OF OXIDATIVE STRESS. AS A COFACTOR, CYSTEINE THIYL RADICALS FACILITATE A WIDE RANGE OF CX (X= H, C, N, O, S, P) BOND CLEAVAGE AND FORMATION REACTIONS WITH HIGH FIDELITY, REQUIRING SELECTIVE THIYL RADICAL GENERATION, ACTIVE SITE CHEMISTRY, AND REDUCTION. THEIR REACTIVITY, PARTICULARLY WITHIN AN ACTIVE SITE WITH MANY WEAK CH BONDS AND OXIDIZABLE AMINO ACID SIDECHAINS PRESENTS SEVERAL ALTERNATIVE FATES, CLEARLY MANIFEST IN THIYL RADICALS GENERATED AS THE PRODUCT OF OXIDATIVE STRESS "OFF PATHWAY," WHERE THEY CAN FORM NEW SS AND SC BONDS, OR CATALYZE OTHER CHEMICAL MODIFICATIONS THAT ARE DELETERIOUS TO BIOLOGICAL FUNCTION. UNDERSTANDING THE STRUCTURE/FUNCTION RELATIONSHIP THAT DICTATES THIYL RADICAL FATE HOLDS PROMISE IN DEVELOPING BETTER THERAPEUTICS AND ANTIBIOTICS THAT TARGET THIYL RADICAL ENZYMES, INFORMING BIOMIMETIC OR BIOCATALYTIC SYNTHETIC BIOLOGY, AND MITIGATING THEIR ROLE IN OXIDATIVE STRESS. UNDERSTANDING THE MECHANISTIC AND CONTEXTUAL ASPECTS OF HOW THIYL RADICALS ARE GENERATED AND WHAT DICTATES THEIR FATE IN PROTEINS ARE ESSENTIAL TO ADDRESSING THEIR IMPACT ON HUMAN HEALTH. OUR RESEARCH GROUP IS SEEKING TO DEFINE HOW THIYL RADICALS THAT ENABLE CATALYSIS ARE SELECTIVELY GENERATED AND MAINTAINED, HOW THIS MIGHT INFORM THERAPEUTIC DEVELOPMENTS, AND WHAT DETERMINES THE FATES OF ORPHANED THIYL RADICALS. TO THESE ENDS, WE ARE EMPLOYING GENETIC, CHEMICAL, AND SPECTROSCOPIC TOOLS TO UNDERSTAND THIYL RADICAL CHEMISTRY WITHIN PROTEINS, FROM GENERATION TO TERMINATION, WITH KINETIC AND THERMODYNAMIC RESOLUTION. AS OUR PROOFOFCONCEPT, WE ARE APPLYING THESE TOOLS TO THE DEVELOPMENT OF MECHANISMBASED INHIBITORS FOR PROMINENT THIYL RADICAL ENZYMES IN THE GUT, TARGETING CLOSTRIDIOIDES DIFFICILE, WITH PRECISION. MORE BROADLY, HOWEVER, BY ADVANCING OUR UNDERSTANDING OF THIYL RADICAL CHEMISTRY IN DIVERSE PROTEIN MILIEU THE RESULTING DISCOVERIES WILL PROVIDE NEW OPPORTUNITIES TO IMPROVE OR TARGET THIYL RADICAL CATALYSIS AND RATIONALIZE OXIDATIVE STRESS PATHWAYS. THROUGH DEVELOPMENTS IN EACH AREA, WE WILL FORM THE FOUNDATION OF A HOLISTIC UNDERSTANDING OF THIYL RADICAL CHEMISTRY IN BIOLOGY THAT WE ANTICIPATE WILL HAVE WIDE RANGING IMPLICATIONS, BOTH IN BASIC AND APPLIED LIFE AND PHYSICAL SCIENCES.

Posted 7/10/24, 12:00 AM